SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 8-K - Current report:
SEC Accession No. 0001193125-23-025588
Filing Date
2023-02-06
Accepted
2023-02-06 16:16:08
Documents
14
Period of Report
2023-02-06
Items
Item 7.01: Regulation FD Disclosure
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq Description Document Type Size
1 8-K d462129d8k.htm   iXBRL 8-K 25185
2 EX-99.1 d462129dex991.htm EX-99.1 13505
6 GRAPHIC g462129g0206041109624.jpg GRAPHIC 3676
  Complete submission text file 0001193125-23-025588.txt   170877

Data Files

Seq Description Document Type Size
3 XBRL TAXONOMY EXTENSION SCHEMA lnth-20230206.xsd EX-101.SCH 2852
4 XBRL TAXONOMY EXTENSION LABEL LINKBASE lnth-20230206_lab.xml EX-101.LAB 17993
5 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE lnth-20230206_pre.xml EX-101.PRE 11262
8 EXTRACTED XBRL INSTANCE DOCUMENT d462129d8k_htm.xml XML 3355
Mailing Address 331 TREBLE COVE ROAD NORTH BILLERICA MA 01862
Business Address 331 TREBLE COVE ROAD NORTH BILLERICA MA 01862 978 671-8001
Lantheus Holdings, Inc. (Filer) CIK: 0001521036 (see all company filings)

IRS No.: 352318913 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 001-36569 | Film No.: 23590851
SIC: 2835 In Vitro & In Vivo Diagnostic Substances